Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.190
+0.290 (15.26%)
At close: Oct 6, 2025, 4:00 PM EDT
2.240
+0.050 (2.28%)
Pre-market: Oct 7, 2025, 4:01 AM EDT
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $21.71 million as of October 6, 2025. Its market cap has increased by 57.30% in one year.
Market Cap
21.71M
Enterprise Value
13.69M
1-Year Change
57.30%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $21.71M, an increase of 10,753.54%. That is a compound annual growth rate of 56.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 18.80M | 79.05% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
| Mar 31, 2015 | 200.00K | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |